Navigation Links
Varian Medical Systems to Showcase New X-Ray Tubes and Flat Panel Detectors at the ECR Annual Meeting
Date:3/3/2011

SALT LAKE CITY, March 3, 2011 /PRNewswire/ -- ECR Booth #313/Expo C - Varian Medical Systems, Inc., X-Ray Products, will be showcasing a comprehensive imaging portfolio of PaxScan® digital image detectors and X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the European Congress of Radiology (ECR) annual  meeting in Vienna, Austria this week.  

"Our exhibit reflects our commitment to the industry's demands for technically advanced X-ray tube and flat panel solutions," said Steve Kimmel, vice president of Sales and Marketing for Varian X-Ray Products.  "The new panel and tube platforms offer a path to improve image quality, greater cost efficiency, and potential for increased patient throughput."

The products to be highlighted at ECR are:

  • The new M-1500, Varian's first X-ray tube developed specifically for advanced mammography applications such as tomosynthesis and CT.  The M-1500 provides exceptional performance in a space efficient design.  "This revolutionary design provides for high throughput and performance in specialized mammography applications," said Dennis Runnoe, vice president of Research and Development Engineering.
  • The new PaxPower FP X-ray tube which is optimized for interventional procedures and portable surgical CT systems.  The new PaxPower FP tube platforms were developed with a smaller footprint and higher power. "This new technology represents a new generation of diagnostic tubes incorporating much of what we have learned over years of anode-grounded CT development.  This new tube technology provides a dramatically smaller and lighter package with higher heat dissipation allowing for higher patient throughput," said Kimmel.
  • The new PaxScan® 3024M flat panel detector designed for full field digital mammography.  The compact design, incorporating a narrow edge and rapid image-acquisition capabilities, enables radiologists to acquire images close to the chest wall with results in seconds.  This architecture is based on amorphous silicon (a-Si) design allowing rapid frame rates for advanced mammographic applications.  "In addition, this exciting new product promises to extend the capabilities of digital mammography into emerging markets where its environmental stability makes it an attractive option over existing technologies," said Rick Colbeth, Research and Development Engineering manager for Varian's PaxScan® Imaging Products.  
  • The new PaxScan® 4336R "hot swap" technology, which allows the radiographic panel to be unplugged and plugged back in without having to reboot the system.  "This new feature easily moves the panel from the X-ray table to a chest stand without interrupting workflow.  There is no longer a need to power down while swapping the panel and the feature enables using one panel per room or one panel across multiple rooms, lowering system costs," added Colbeth.

  • Continuing the commitment to innovation, Varian will highlight other tubes and flat panel detectors designed for space efficiency and high performance.About Varian Medical SystemsVarian X-Ray Products is a premier supplier of X-ray tubes and digital detectors for X-ray imaging in medical, dental, veterinary, scientific, and industrial applications.  Varian's X-Ray Products manufacturing headquarters are located in Salt Lake City, Utah.  The division also has sales and service centers in Charleston, South Carolina, Beijing, China and Willich, Germany where these facilities reload, rebuild and distribute medical X-ray tubes for immediate delivery throughout the world.X-Ray Products is a business unit of Varian Medical Systems, Inc., of Palo Alto, California.  Varian is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy.  The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices.  The company also supplies X-ray imaging products for cargo screening and industrial non-destructive inspection.  Varian Medical Systems employs approximately 5,300 people who are located at manufacturing sites in North America, China and Europe and in its 70 sales and support offices around the world. For more information, visit http://www.varian.com/.FOR INFORMATION CONTACT:Elaine Rebele, Varian Medical Systems801-978-5715   elaine.rebele@varian.com
    '/>"/>

    SOURCE Varian Medical Systems, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
    2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
    3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
    4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
    5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
    6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
    7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
    8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
    9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
    10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
    11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/16/2017)... 2017  Newly published research from the CVS Health ... role a private retailer can play in restricting access ... online today in the American Journal of Public ... tobacco from all CVS Pharmacy stores reduced the number ... even greater impact on those who bought cigarettes exclusively ...
    (Date:2/16/2017)... Calif. , Feb. 16, 2017  AcelRx ... specialty pharmaceutical company focused on the development and ... moderate-to-severe acute pain, announced that Vincent J. ... and a member of the company,s board of ... brings over two decades of experience leading executive ...
    (Date:2/16/2017)... WASHINGTON , Feb. 16, 2017  Prescription pain ... emergency department visit are necessary for long-term opioid use ... the Feb. 16 th edition of The ... "Emergency physicians see more patients in acute pain ... Rebecca Parker , MD, FACEP, president of the American ...
    Breaking Medicine Technology:
    (Date:2/17/2017)... ... February 17, 2017 , ... MAP ... today that Karen Pilley has been promoted to Chief Executive Officer. , ... healthcare paradigm – a shift that demands the transition from pay-for-service to pay-for-performance ...
    (Date:2/17/2017)... , ... February 17, 2017 , ... ... Chief Executive Officer, George Rogers, was named to Staffing Industry Analysts' 2017 "Staffing ... 100 honors those who have made notable contributions to the staffing industry over ...
    (Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... Like most ... reduce readmissions. Driven in large part by the Hospital Readmission Reduction Program (HRRP), the ... a key focus area for hospitals across the nation. While many providers are struggling ...
    (Date:2/17/2017)... ... February 17, 2017 , ... ... planning assistance to families and business owners in and around the Hampton Roads ... to help prevent all forms of domestic violence. , There are multiple categories ...
    (Date:2/16/2017)... ... February 17, 2017 , ... Harsha Chigurupati ... years of research, development and clinical trials, the founder of Chigurupati Technologies has ... compound of FDA approved ingredients that when infused into alcohol, protect the consumer’s ...
    Breaking Medicine News(10 mins):